In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-10 of 10 for your search:
Drug:  recombinant human endostatin
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 70
Sponsor: Other
Protocol IDs: ECF/endo-MGC, NCT00595972

2.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 70
Sponsor: Other
Protocol IDs: Endostar B-01, XOBCR01, NCT00604435

3.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 75
Sponsor: Pharmaceutical / Industry
Protocol IDs: XYL014, NCT00708812

4.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 to 75
Sponsor: Pharmaceutical / Industry
Protocol IDs: SIM-69, NCT00912392

5.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor: Other
Protocol IDs: DP-EN-RT, NCT01218594

6.

Phase: Phase II
Type: Diagnostic, Treatment
Status: Closed
Age: 18 to 70
Sponsor: Other
Protocol IDs: XIANSHENG, NCT01347424

7.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: ZhejaingCH-npc-02, NCT01612286

8.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02314, MDA-ID-99201, NCI-T99-0087, CDR0000067471, T99-0087, NCT00004229

9.

Phase: Phase I
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: CDR0000067532, P30CA014520, WCCC-CO-99910, NCI-T99-0055, T99-0055, NCT00004872

10.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 to 70
Sponsor: Other
Protocol IDs: SIM-93, NCT01531790
New Search